RecruitingNCT04616495
Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases
Sponsor
Hospital Universitario La Fe
Enrollment
30 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Multicentric prospective and observational study to assess the 5-year overall survival in a cohort of patients with unresectable liver-only colorectal metastases, well controlled by chemotherapy prior to liver transplantation.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Plain Language Summary
Simplified for easier understanding
This study is exploring whether liver transplantation is a viable treatment option for carefully selected people with colorectal cancer that has spread only to the liver and cannot be surgically removed. Standard treatment does not include transplant for this condition, so this trial is testing a new approach.
**You may be eligible if...**
- You are 18 or older
- You had colorectal cancer that was completely removed (R0 resection) previously
- Your cancer has spread only to the liver and cannot be surgically removed
- Your liver metastases responded to 1–2 lines of chemotherapy
- You have been cancer-free elsewhere for at least 1 year before being listed for transplant
- You are in good health (ECOG 0 or 1)
**You may NOT be eligible if...**
- Your cancer has spread outside the liver
- Your tumor has a BRAF mutation
- You are HIV or Hepatitis C positive
- You are overweight (BMI ≥ 30) or have lost significant weight recently
- You are pregnant
- You have another active cancer
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURELiver transplantation
Chemotherapy and liver transplantation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04616495
Related Trials
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
NCT0706665720 locations
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
NCT072819241 location
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT0697411015 locations
IDOV-Immune for Advanced Solid Tumors
NCT069106575 locations
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
NCT0752520627 locations